Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT03655964
Effect of Olmesartan and Nebivolol on Ambulatory Blood Pressure and Arterial Stiffness in Acute Stage of Ischemic Stroke
60
Enrollment(s)
1
Study location(s)
Interventional (Phase II)
Stroke, Ischemic
Completed
NCT03244319
Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)
220
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
MV(Mitral Valve) Repair
Completed
NCT00697203
A Study to Assess the Effect of RO4607381 in Patients With Relatively Low Levels of High Density Lipoprotein-Cholesterol (HDL-C)
292
Enrollment(s)
0
Study location(s)
Interventional (Phase II)
Dyslipidemia
Completed
NCT01565668
Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
76
Enrollment(s)
24
Study location(s)
Interventional (Phase II)
Leukemia, Myeloid, Acute
Completed
NCT02952599
Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)
352
Enrollment(s)
19
Study location(s)
Observational
Venous Thromboembolism
Completed
NCT04185857
MRA and ARB Treatment in Screening of Primary Aldosteronism
50
Enrollment(s)
1
Study location(s)
Observational
Primary Aldosteronism Due to Aldosterone Producing Adenoma
Unknown status
NCT04138888
A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration Under Fasting Conditions
32
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Bioequivalence
Unknown status
NCT04161001
Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
237
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Hypertension, Dyslipidemia
51
52
53
54
55